All News
|
News Release
NIH supported study shows that the virus that causes COVID-19 can damage the heart without directly infecting heart tissue SARS-CoV-2, the virus that causes COVID-19, can damage the heart even without directly infecting the heart tissue, a National Institutes of Health-supported study has found. The research, published in the journal Circulation...
Showing 10 out of 202 results
|
Research Feature
In English El NHLBI y la anemia de células falciformes El NHLBI ha investigado la anemia de células falciformes desde su fundación en 1948 como Instituto Nacional del Corazón (National Heart Institute). Desde 1972, cuando se aprobó la Ley Nacional de Control de la Anemia de Células Falciformes, el NHLBI ha gastado más de mil millones de dólares...
|
Research Feature
|
Research Feature
|
Research Feature
In 1993, the NHLBI’s Women's Health Initiative (WHI) began enrolling the first participants in what would become one of the most definitive, far-reaching clinical trials of post-menopausal women's health ever undertaken in the U.S. During its more than 20 years of work, this long-term national health study of 161,808 women aged 50-79 has focused on...
|
Research Feature
|
Research Feature
|
Research Feature
Tremendous progress in the treatment of HIV has led to increased survival and a dramatic evolution of the disease’s course in patients. The clinical challenges confronting the population have now shifted from AIDS-related illnesses to chronic diseases, such as coronary artery disease, chronic obstructive lung disease, and chronic anemia. Multiple...
|
Research Feature
Results from the COAG study were published in the New England Journal of Medicine on November 19, 2013, to coincide with a presentation of the study findings at the American Heart Association (AHA) Scientific Sessions in Dallas. The NIH-funded clinical trial found that combining genetic data with clinical information to determine the initial dosage...
|
Research Feature
|
Research Feature
Is the randomized registry trial the next “disruptive technology” in clinical research? That is the question posed and discussed by Dr. Michael Lauer , director of the NHLBI’s Division of Cardiovascular Sciences, and co-author Dr. Ralph B. D’Agostino from Boston University and the Harvard Clinical Research Institute in their recent New England...